Three year outcomes of intravitreal ranibizumab and aflibercept treatment of patients with diabetic macular edema: A comparative study

BACKGROUND: Diabetic macular edema (DME) is the most common cause of visual deterioration in patients with diabetes mellitus. Various treatment options have been used for DME, including intravitreal injection of steroids and anti-vascular endothelial growth factors. OBJECTIVES: To evaluate and compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbas, Yusuf Berk, Alagoz, Cengiz, Cakmak, Semih, Demir, Gokhan, Alagoz, Nese, Artunay, Halil Ozgur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464826/
https://www.ncbi.nlm.nih.gov/pubmed/37649968
http://dx.doi.org/10.1177/25158414231195174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464826/
https://www.ncbi.nlm.nih.gov/pubmed/37649968
http://dx.doi.org/10.1177/25158414231195174

Ejemplares similares